Platinum Open Access
Swiss Medical Weekly, which began publication in 1871 as “Correspondenz-Blatt für Schweizer Aerzte”, is an international peer-reviewed medical journal following the Platinum Open Access model. Platinum Open Access means that the articles are published fully open access and that the journal does not charge any APCs (article-processing charges).
The "Swiss Medical Weekly" is supported by the Swiss Academy of Medical Sciences (SAMS) and the Swiss Medical Association (FMH).
The quality of SMW publications is guaranteed by a consistent policy of rigorous single-blind peer review. All editorial decisions are made by research-active academics. The large number of reviews fills its pages with a wide range of cutting edge but also established themes.
The Swiss Medical Weekly is the official scientific publication of the Swiss Society of General Internal Medicine, the Swiss Society of Infectiology, the Swiss Society of Rheumatology and the Swiss Society of Pulmonary Hypertension.
Previous titles:
Correspondenz-Blatt für Schweizer Aerzte (1871-1919)
Schweizerische Medizinische Wochenschrift / Journal Suisse de Médecine (Schweiz Med Wochenschr) (1920-2000)
The Swiss Medical Weekly has played a decisive role in Swiss clinical research.
Metrics
Swiss Medical Weekly in "Dimensions": most cited articles
Swiss Medical Weekly in "Google Scholar": h5 index = 33
Editorial board
Prof. Dr. med. Adriano Aguzzi
Editor in chief
Institute Director, Institute of Neuropathology, UniversitätsSpital Zürich, Switzerland
Prof. Dr. med. Manuel Battegay
Deputy editor in chief
Chief of the Division for Infectious Diseases and Hospital Epidemiology, University Hospital, Basel, Switzerland
Prof. Dr. med. Jean-Michel Dayer
Editor
Emeritus Professor of Medicine of the University of Geneva, Switzerland
Prof. Dr. med. Christian Seiler, MHA, FACS
Editor
Co-chairman of cardiology at the University Hospital, Bern, Switzerland
Prof. Dr. med. André P. Perruchoud
Senior editor
Emeritus Professor of Medicine of the University of Basel, Switzerland
Prof. Dr. med. Peter Suter
Senior editor
Emeritus Professor of Medicine of the University of Geneva, Switzerland
Your contacts in the editing company
Natalie Marty, MD
Head of publications
e-mail: Natalie Marty
tel. +41 (0)61 467 85 50
Katharina Blatter, Dr. phil.
Managing editor
e-mail: Katharina Blatter
Tel. +41 (0)61 467 85 25
Gisela Wagner
Editorial office
e-mail: Gisela Wagner
tel. +41 (0)61 467 85 52
Imprint
Swiss Medical Weekly
Mode of publication: continuous online publication
ISSN: 1424-3997
Title abbreviation: Swiss Med Wkly
Abstracted/indexed in Index Medicus / MEDLINE; Dimensions; Current Contents / Science Citation Index; EMBASE
Formerly: Schweizerische medizinische Wochenschrift (1920-2000, ISSN: 0036-7672, eISSN 1424-3997) and Correspondenz-Blatt für Schweizer Ärzte (1871-1919, ISSN 0366-5461)
Picture credits: please click here
Editing company
EMH Swiss Medical Publishers Ltd.
Farnsburgerstrasse 8
CH-4132 Muttenz
Tel. +41 (0)61 467 85 55
Fax +41 (0)61 467 85 56
e-mail: EMH
www.emh.ch
Dr. med. et lic. phil. Bruno Kesseli
Editor in chief Swiss Medical Journal
e-mail: Bruno Kesseli
Tel. +41 (0)61 467 85 51
Dr. phil. II Karin Würz
Manager of marketing and communication
e-mail: Karin Würz
Tel. +41 (0)61 467 85 49
Dr. med. Natalie Marty
Head of publications
e-mail: Natalie Marty
Tel. +41 (0)61 467 85 50
Dr. Sandra Ziegler
Managing director
e-mail: Sandra Ziegler
Tel. +41 (0)61 467 85 89
Open access license
"Swiss Medical Weekly" is an open access publication of EMH published in accordance with the terms of the Creative Commons licence attribution - NonCommercial - NoDerivatives 4.0 International. You are free to share, copy and redistribute the material in any medium or format under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
"Non-commercial" means not primarily intended for or directed towards commercial advantage or monetary compensation. The incorporation of publications in commercial products, the use of publications to advertise for commercial products or services and any other usage that directly or indirectly pursues commercial interests is subject to the express previous consent of the publishing house as part of a written agreement.
Please send us your request in writing. Exact indication of the publication from which you would like to reproduce material and detailed information about its intended use help to facilitate and expedite request processing.
Your opinion is important to us
Do not hesitate to contact us: we are looking forward to your comments and suggestions!
